Replimune Group (REPL) Earnings Date, Estimates & Call Transcripts $12.09 -0.41 (-3.28%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$12.23 +0.14 (+1.16%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Replimune Group Earnings Summary Replimune Group announced Q4 2025 earnings on May 22, 2025, reporting an EPS of -$0.82, which missed analysts' consensus estimates of -$0.75 by $0.07. With a trailing EPS of -$3.07, Replimune Group's earnings are expected to grow next year, from ($2.97) to ($2.55) per share. Upcoming Q1 Earnings DateAug. 14Before Market OpensEstimatedConsensus EPS (May. 22) -$0.75 Actual EPS (May. 22) -$0.82 Missed By -$0.07 Q4 2025 Earnings ResourcesQ4 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Report Annual Report (10-K)SEC FilingREPL Upcoming EarningsReplimune Group's Q1 2026 earnings is scheduled for Thursday, August 14, 2025, with a conference call scheduled on Thursday, August 7, 2025 at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Replimune Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Replimune Group and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataREPL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Replimune Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.85-$0.70-$0.77Q2 20254-$0.87-$0.70-$0.79Q3 20254-$0.88-$0.63-$0.74Q4 20254-$0.90-$0.69-$0.79 FY 2025 15 -$3.50 -$2.72 -$3.08 Q1 20263-$0.92-$0.70-$0.82Q2 20263-$0.96-$0.63-$0.78Q3 20264-$0.93-$0.52-$0.69Q4 20264-$0.85-$0.52-$0.65 Replimune Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)--------5/22/2025Q4 2025-$0.75-$0.82 -$0.07-$0.82--2/12/2025Q3 2025-$0.70-$0.79 -$0.09-$0.79--11/12/2024--$0.75-$0.68+$0.07-$0.68--8/8/2024--$0.88-$0.78+$0.10-$0.78--5/16/2024Q4 2024-$0.86-$0.82+$0.04-$0.82--2/8/2024Q3 2024-$0.89-$0.77+$0.12-$0.77--11/7/2023Q2 2024-$0.80-$0.90 -$0.10-$0.90--8/3/2023Q1 2024-$0.80-$0.75+$0.05-$0.75-- Replimune Group Earnings - Frequently Asked Questions When is Replimune Group's earnings date? Replimune Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on REPL's earnings history. Did Replimune Group beat their earnings estimates last quarter? In the previous quarter, Replimune Group (NASDAQ:REPL) missed the analysts' consensus estimate of ($0.75) by $0.07 with a reported earnings per share (EPS) of ($0.82). Learn more on analysts' earnings estimate vs. REPL's actual earnings. How can I listen to Replimune Group's earnings conference call? The conference call for Replimune Group's latest earnings report can be listened to online. Listen to Conference Call How can I read Replimune Group's conference call transcript? The conference call transcript for Replimune Group's latest earnings report can be read online. Read Transcript How can I view Replimune Group's earnings report? Replimune Group's earnings report can be found in their filing with the SEC. View SEC filing How much profit does Replimune Group generate each year? Replimune Group (NASDAQ:REPL) has a recorded net income of -$247.30 million. REPL has generated -$3.07 earnings per share over the last four quarters. What is Replimune Group's EPS forecast for next year? Replimune Group's earnings are expected to grow from ($2.97) per share to ($2.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies Protagonist Therapeutics Earnings Date MoonLake Immunotherapeutics Earnings Date Immunovant Earnings Date Crinetics Pharmaceuticals Earnings Date Kymera Therapeutics Earnings Date Ultragenyx Pharmaceutical Earnings Date Alvotech Earnings Date Amneal Pharmaceuticals Earnings Date Mirum Pharmaceuticals Earnings Date Catalyst Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Netflix Q2 2025 Earnings: What Investors Need to KnowHow Goldman Sachs Earnings Help You Strategize Your PortfolioCitigroup Earnings Could Signal What’s Next for Markets3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings Report This page (NASDAQ:REPL) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Replimune Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Replimune Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
